Literature DB >> 28026113

Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.

Atsushi Suzuki1, Hiroyuki Taniguchi1, Masahiko Ando2, Yasuhiro Kondoh1, Tomoki Kimura1, Kensuke Kataoka1, Toshiaki Matsuda3, Toshiki Yokoyama1, Koji Sakamoto3, Yoshinori Hasegawa3.   

Abstract

INTRODUCTION: Acute exacerbation (AE) is a severe complication of idiopathic pulmonary fibrosis (IPF), which shares some common pathological features with acute respiratory distress syndrome (ARDS). The new definition of ARDS requires positive end-expiratory pressure (PEEP) to assess gas exchange and has better predictive validity for short-term mortality compared with the previous definition.
OBJECTIVES: The aim of this study was to evaluate the prognostic utility of oxygenation with PEEP in AE-IPF.
METHODS: We performed a retrospective cohort study using the data of AE-IPF patients between 2007 and 2015. At the time of diagnosis, PaO2 /FiO2 was evaluated before and 30 minutes after PEEP. We evaluated the prognostic utility of PaO2 /FiO2 with PEEP after including other candidate prognostic factors. Considering the definition of ARDS, patients with AE-IPF were classified into a severe group (PaO2 /FiO2  ≤ 300 with PEEP) and a non-severe group (PaO2 /FiO2  > 300 with PEEP).
RESULTS: We identified 62 consecutive patients with AE-IPF. All patients were treated with mechanical ventilation on the first day. The median PaO2 /FiO2 before and 30 minutes after PEEP was significantly increased (237.5-425.5, P < .001). In multivariate Cox proportional analysis, Krebs von den Lungen-6 (KL-6) (HR 1.239; 95%CI 1.050-1.461; P = .011), D-dimer (HR 1.039; 95%CI 1.015-1.064; P = .001), % neutrophils in bronchoalveolar lavage fluid (HR 1.015; 95%CI 1.003-1.027; P = .017), and being in the severe group (HR 3.233; 95%CI 1.503-6.957; P = .003) had significant impacts on survival up to 90 days.
CONCLUSION: Evaluation of oxygenation with PEEP may provide useful information for predicting short-term mortality in patients with AE-IPF.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  acute exacerbation; acute respiratory distress syndrome; idiopathic pulmonary fibrosis; mechanical ventilation; positive end-expiratory pressure

Mesh:

Substances:

Year:  2017        PMID: 28026113     DOI: 10.1111/crj.12602

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  7 in total

Review 1.  Contemporary approaches in the use of extracorporeal membrane oxygenation to support patients waiting for lung transplantation.

Authors:  Steven P Keller
Journal:  Ann Cardiothorac Surg       Date:  2020-01

2.  The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMC Pulm Med       Date:  2020-03-02       Impact factor: 3.317

3.  Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.

Authors:  Takahito Suzuki; Hironao Hozumi; Koichi Miyashita; Masato Kono; Yuzo Suzuki; Masato Karayama; Kazuki Furuhashi; Hirotsugu Hasegawa; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Koshi Yokomura; Hidenori Nakamura; Takafumi Suda
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

4.  Acute exacerbation of idiopathic pulmonary fibrosis triggered by Aspergillus empyema.

Authors:  Atsushi Suzuki; Tomoki Kimura; Kensuke Kataoka; Toshiaki Matsuda; Toshiki Yokoyama; Yuta Mori; Yasuhiro Kondoh
Journal:  Respir Med Case Rep       Date:  2018-01-31

5.  Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern.

Authors:  Meng-Shu Cao; Jian Sheng; Tian-Zhen Wang; Xiao-Hua Qiu; Dong-Mei Wang; Yang Wang; Yong-Long Xiao; Hou-Rong Cai
Journal:  Chin Med J (Engl)       Date:  2019-09-20       Impact factor: 2.628

6.  Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMJ Open       Date:  2020-06-15       Impact factor: 2.692

7.  KL-6 as an Immunological Biomarker Predicts the Severity, Progression, Acute Exacerbation, and Poor Outcomes of Interstitial Lung Disease: A Systematic Review and Meta-Analysis.

Authors:  Tao Zhang; Ping Shen; Chunyan Duan; Lingyun Gao
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.